|
2023
|
Invention
|
Novel n-acyl-[3-substituted]-[8-substituted]-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selec... |
|
2022
|
Invention
|
Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat.
Disclosed is... |
|
2020
|
Invention
|
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective n... |
|
|
Invention
|
Chiral n-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 r... |
|
|
Invention
|
Nk-3 receptor antagonists for therapeutic treatment of leptin-related disease. Disclosed is use o... |
|
2019
|
Invention
|
D3 deuterated form thereof. 1 represents methyl or methyl-d3, thus corresponding to 3-methyl-1,2,... |
|
|
Invention
|
D3 deuterated form thereof. The present invention relates to a method of synthesis of compound (I... |
|
|
Invention
|
Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-d3 deuterated form ther... |
|
|
Invention
|
Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for us... |
|
|
Invention
|
Chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyra... |
|
2018
|
Invention
|
Deuterated fezolinetant. Deuterated fezolinetant (R)-(4-fluorophenyl)-(8-methyl-3-(3-(methyl-d3)-... |
|
|
Invention
|
Deuterated fezolinetant. Rd3d3)-1,2,4-thiadiazol-5-yl)-5,6-dihydio-[1,2,4]trizolo[4,3-a]pyrazin-7... |
|
|
Invention
|
N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 recep... |
|
|
Invention
|
Nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in n... |
|
2017
|
Invention
|
N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 r... |
|
2016
|
Invention
|
Chiral n-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 ... |
|
|
Invention
|
Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor antagonists. Novel compoun... |
|
|
Invention
|
Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat. Disclosed is ... |
|
|
Invention
|
Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat. Described her... |
|
|
Invention
|
Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat. The present i... |
|
2015
|
Invention
|
Novel chiral synthesis of n-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-... |
|
2014
|
Invention
|
Novel n-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3... |
|
|
Invention
|
Novel n-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective ... |
|
2012
|
Invention
|
N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective nk-3 receptor... |
|
2009
|
Invention
|
Methods of making an antibody that binds a chemerin polypeptide. The present invention relates to... |
|
2008
|
Invention
|
Nucleic acids encoding chemerinr ligands. The present invention relates to a G-protein coupled re... |
|
|
Invention
|
Nucleic acids encoding a heme binding protein polypeptide. The present invention relates to metho... |
|
|
Invention
|
Ligand for g-protein coupled receptor fprl2. The present invention relates to methods, reagents a... |
|
2007
|
Invention
|
Compositions comprising a ligand of chemerin r. The present invention relates to a G-protein coup... |
|
|
Invention
|
Methods of identifying modulators of chemerinr polypeptides. The present invention relates to a G... |
|
|
Invention
|
Ligand for g-protein coupled receptor gpr72 and uses thereof. The present invention relates to me... |
|
2006
|
Invention
|
Functional antibodies that specifically bind to the chemerin receptor. The present invention rela... |
|
|
Invention
|
Antibody that specifically binds to chemerin receptor ligand precursor. The present invention rel... |
|
|
Invention
|
Antibody against g-protein coupled receptor showing selective affinity for atp and uses therefor.... |
|
2005
|
Invention
|
Ligand for g-protein coupled receptor fprl2 and uses thereof. The present invention relates to me... |
